Assisted Reproductive Technology (ART) Storage Funding Program

Overview

The purpose of this grant opportunity is to support patients from two population groups who face extra costs associated with fertility preservation: people who require fertility treatment, including fertility preservation, due to a cancer diagnosis, and people at risk of passing on genetic conditions who have undergone pre-implantation genetic testing funded by the Medicare Benefit Schedule (MBS), as described in MBS items 13207, 73384, 73385, 73386 or 73387.  Costs associated with the cryostorage of eggs, sperm or embryos are not currently subsidised through the Medical Benefits Schedule (MBS) and these patient groups often face extra costs associated with fertility preservation. The intended outcome of the program is to reduce eligible patient’s costs for preserving eggs, sperm, or embryos through cryostorage (freezing). Under the program, patients will be eligible for up to ten years of cryostorage funding per eligible material stored. To view the grant opportunity documents, please select the red Grant Opportunity Documents button on the left hand side.